These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 3023210)
61. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease. Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573 [TBL] [Abstract][Full Text] [Related]
62. 5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo. De Clerck F; Loots W; Somers Y; Beetens J; Wouters L; Wynants J; Janssen PA Br J Pharmacol; 1990 Apr; 99(4):631-6. PubMed ID: 2113823 [TBL] [Abstract][Full Text] [Related]
63. Stimulation of prostacyclin production in blood vessels by the antithrombotic drug suloctidil. Boeynaems JM; Van Coevorden A; Demolle D Biochem Pharmacol; 1987 May; 36(10):1629-35. PubMed ID: 3036152 [TBL] [Abstract][Full Text] [Related]
64. Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Schulman ES; Newball HH; Demers LM; Fitzpatrick FA; Adkinson NF Am Rev Respir Dis; 1981 Oct; 124(4):402-6. PubMed ID: 6170242 [TBL] [Abstract][Full Text] [Related]
65. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine. Stuart MJ; Dusse J; Clark DA; Walenga RW Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080 [TBL] [Abstract][Full Text] [Related]
66. Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2. FitzGerald GA; Lupinetti M; Charman SA; Charman WN J Pharmacol Exp Ther; 1991 Dec; 259(3):1043-9. PubMed ID: 1762060 [TBL] [Abstract][Full Text] [Related]
67. Alterations of the prostacyclin-thromboxane ratio in streptozotocin induced diabetic rats. Karpen CW; Pritchard KA; Merola AJ; Panganamala RV Prostaglandins Leukot Med; 1982 Feb; 8(2):93-103. PubMed ID: 6804992 [TBL] [Abstract][Full Text] [Related]
68. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R; Nenci GG; Gresele P J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121 [TBL] [Abstract][Full Text] [Related]
69. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis. Keimowitz RM; Pulvermacher G; Mayo G; Fitzgerald DJ Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418 [TBL] [Abstract][Full Text] [Related]
70. The combined effects of sodium salicylate, aspirin and indomethacin on the metabolism of arachidonic acid in human platelets. Dahl ML; Uotila P Prostaglandins Leukot Med; 1984 Oct; 16(1):95-107. PubMed ID: 6440154 [TBL] [Abstract][Full Text] [Related]
71. Effects of repeated oral doses of fenflumizole on platelet aggregation and thromboxane formation in man ex vivo. Dahl-Puustinen ML; Corell T; Koch K; Puustinen T Prostaglandins Leukot Essent Fatty Acids; 1988 Feb; 31(2):101-6. PubMed ID: 3357910 [TBL] [Abstract][Full Text] [Related]
72. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs. Tanabe M; Terashita Z; Nishikawa K; Hirata M J Cardiovasc Pharmacol; 1984; 6(3):442-8. PubMed ID: 6202970 [TBL] [Abstract][Full Text] [Related]
73. Recovery of prostacyclin synthesis by rabbit aortic endothelium and other tissues after inhibition by aspirin. Frazer CE; Ritter JM Br J Pharmacol; 1987 May; 91(1):251-6. PubMed ID: 3297227 [TBL] [Abstract][Full Text] [Related]
74. Thromboxane A2 generation by the larval cestode, Taenia taeniaeformis. Leid RW; McConnell LA Clin Immunol Immunopathol; 1983 Jul; 28(1):67-76. PubMed ID: 6409486 [TBL] [Abstract][Full Text] [Related]
75. In vitro effect of unsaturated fatty acids on the balance between thromboxane A2 and prostacyclin in the blood vascular system. Srivastava KC; Awasthi KK Prostaglandins Leukot Med; 1983 Dec; 12(4):449-59. PubMed ID: 6422477 [TBL] [Abstract][Full Text] [Related]
76. Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids. Lagarde M; Guichardant M; Ghazi I; Dechavanne M Prostaglandins; 1980 Apr; 19(4):551-7. PubMed ID: 7384555 [TBL] [Abstract][Full Text] [Related]
77. Antithrombotic actions of aspirin in the horse. Cambridge H; Lees P; Hooke RE; Russell CS Equine Vet J; 1991 Mar; 23(2):123-7. PubMed ID: 1904347 [TBL] [Abstract][Full Text] [Related]
78. Impaired thromboxane production by newly formed platelets after aspirin administration to thrombocytopenic rats. Dejana E; Barbieri B; Cerletti C; Livio M; de Gaetano G Br J Haematol; 1980 Nov; 46(3):465-9. PubMed ID: 7448129 [TBL] [Abstract][Full Text] [Related]
79. Redirection of arachidonic acid metabolism by ICI D1542: effects on thrombus formation in the coronary artery of the anaesthetized dog. McAuliffe SJ; Moors JA; Snow HM; Wayne M; Jessup R Br J Pharmacol; 1993 Apr; 108(4):901-6. PubMed ID: 8485629 [TBL] [Abstract][Full Text] [Related]
80. Effect of acetaminophen and salicylate on aspirin-induced inhibition of human platelet cyclo-oxygenase. Rao GH; Reddy KR; White JG Prostaglandins Leukot Med; 1982 Jul; 9(1):109-15. PubMed ID: 6813873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]